Lin, Cerritos
Chung-An Lin, Cerritos, CA US
Patent application number | Description | Published |
---|---|---|
20100321386 | Indirect Binding With Segmented Thin Layers to Provide Shape-Preserving Deformations in Computer Animation - A method for use in deformation of an object. The method includes providing a high-resolution model of the object and providing a control cage for the model that includes control faces each defined by control vertices. The method includes generating a thin-layer segment for each of the control faces including extruding a set of the control vertices a distance toward the model. The method includes binding the control cage to the high resolution model based on the thin-layer segments. Each of the thin-layer segments includes a segmented mesh corresponding to a set of the control faces surrounding each face as it is used as seed for a segment. The method includes determining heat diffusion weights for the segments and using the weights along with mean value coordinates to statically bind the cage to the model and to determine influences of segments during deformation of the model with the cage. | 12-23-2010 |
Steven Lin, Cerritos, CA US
Patent application number | Description | Published |
---|---|---|
20100138519 | Networking Hardware Elements With Network Layout Maps Thereon, And Related Methods - Examples of networking hardware with network layout maps thereon are disclosed herein. Other examples, embodiments, and related methods are also described herein. | 06-03-2010 |
Wei-Jen Lin, Cerritos, CA US
Patent application number | Description | Published |
---|---|---|
20090004225 | TOXIN COMPOUNDS WITH ENHANCED MEMBRANE TRANSLOCATION CHARACTERISTICS - The present invention relates to a compound comprising a toxin linked to a translocator. Non-limiting examples of toxins of the present invention are botulinum toxin, butyricum toxin, tetani toxins and the light chains thereof. In some embodiments, the translocator of the present invention comprises a protein transduction domain. | 01-01-2009 |
20100273985 | POST-TRANSLATIONAL MODIFICATIONS AND CLOSTRIDIAL NEUROTOXINS - The present invention discloses modified neurotoxins with altered biological persistence. In one embodiment, the modified neurotoxins are derived from Clostridial botulinum toxins. Such modified neurotoxins may be employed in treating various conditions, including but not limited to muscular disorders, hyperhidrosis, and pain. | 10-28-2010 |
20100273986 | POST-TRANSLATIONAL MODIFICATION AND CLOSTRIDIAL NEUROTOXINS - The present invention discloses modified neurotoxins with altered biological persistence. In one embodiment, the modified neurotoxins are derived from Clostridial botulinum toxins. Such modified neurotoxins may be employed in treating various conditions, including but not limited to muscular disorders, hyperhidrosis, and pain. | 10-28-2010 |
20110046356 | POST-TRANSLATIONAL MODIFICATIONS AND CLOSTRIDIAL NEUROTOXINS - The present invention discloses modified neurotoxins with altered biological persistence. In one embodiment, the modified neurotoxins are derived from Clostridial botulinum toxins. Such modified neurotoxins may be employed in treating various conditions, including but not limited to muscular disorders, hyperhidrosis, and pain. | 02-24-2011 |
20120135495 | NEUROTOXINS WITH ENHANCED TARGET SPECIFICITY - Modified neurotoxins that contain protease cleavage sites susceptible uniquely to proteases present in certain tissues are described. The toxins can be selectively activated by proteases in muscle or selectively inactivated by proteases in blood. | 05-31-2012 |
Yah-Hwa E. Lin, Cerritos, CA US
Patent application number | Description | Published |
---|---|---|
20090047410 | RTH Risotto - A process for the production of a shelf-stable ready-to heat risotto food product that includes the steps of: providing a blend of parboiled and non-parboiled rice grains, filling a plurality of retortable containers with the blend of rice grains and adding the ingredients of oil, water and seasonings to each container. Each container is then sealed and sterilized. After heating by a consumer, the risotto food product has a texture comparable to traditionally prepared risotto. Also provided is shelf stable, ready-to-eat risotto food product having a blend of parboiled and non-parboiled rice grains; wherein the blend of parboiled and non-parboiled rice grains provide a surface creaminess and al dente texture of traditionally prepared risotto. | 02-19-2009 |
20090148562 | Whole Grain Rice Compositions and Coating Methods - The present invention relates to compositions of matter comprising a rice grain, which has been at least partially milled, and, on the surface of the rice grain, a coating comprising bran, a material which increases the fiber value of the composition, or a combination thereof. The present invention provides for compositions that may have the benefits of traditional white rice, i.e., soft mouth feel, short cook times, easy to digest, white appearance, long shelf-life, etc., with the benefits of brown rice, i.e., high nutritional value and enhanced flavor. Indeed, the nutritional value of the compositions of the present invention may be equal to or better than that of wholegrain brown rice. The present invention further relates to methods for the preparation of a whole grain rice composition. In one embodiment the methods comprises at least partially milling rice grains, and coating on the surface of the rice grains, a coating comprising bran, a material which increases the fiber value of the composition, or a combination thereof. | 06-11-2009 |
Yi-Wen Lin, Cerritos, CA US
Patent application number | Description | Published |
---|---|---|
20140350085 | NOVEL SUGAR ALCOHOL-BASED COMPOSITIONS FOR DELIVERING NUCLEIC ACID-BASED DRUGS IN VIVO AND IN VITRO - This invention relates to a composition and its use for formulating nucleic acid-based drugs/vaccines with sugar alcohol compositions into complexes for both in-vitro and in-vivo delivery. Particularly, the present invention includes the ingredients and processes necessary for formulating therapeutic and pharmaceutical nucleic acid compositions, such as miRNA, microRNA precursors, shRNAs, siRNAs, ribozymes, antisense RNAs/DNAs, RNA-DNA hybrids and DNA vectors/vaccines, with glycylated sugar alcohols/sugars into delivery complexes, which can then be absorbed by cells in vivo and in vitro via active endocytosis. Also, the present invention discloses that chemical compounds containing sugar alcohol- and/or sugar-like structures can protect nucleic acids, in particular miRNAs, shRNAs, siRNAs and ribozymes, from degradation in vivo as well as in vitro. Therefore, the present invention is also a formula and method for preserving the structural integrity and functional efficacy of these nucleic acid-based drugs and/or vaccines in vivo and in vitro. | 11-27-2014 |